Introduction - Your latest trial sponsor is using AI to accelerate protocol development and patient recruitment,[1] cutting ...

As MRD (minimal residual disease) becomes a decision-driving component of oncology development, the challenge is how to execute it reliably at scale. Translating MRD from strategy into practice ...

We’ve been discussing simplifying protocol designs for decades. And yet, a phase III protocol today collects nearly 6 million data points on average; a figure that’s been climbing by roughly 11% ...

Teaching people efficiently isn’t limited to transmitting material from one head to another — it’s also about conveying the principles that got us there. [Mara Bos] shows us a toolkit (Twitter, nitter ...

Successful clinical trial conduct balances participant safety, treatment efficacy and operational feasibility. But slow patient identification and enrollment, cost overruns and missed deadlines pose a ...

Timing of Adjuvant Chemotherapy After Gastrectomy in Patients With Stage II to III Gastric Cancer: A Target Trial Emulation Study Master protocols represent transformations, enabling multiple ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...